Determine the necessary mass, volume, or concentration for preparing a solution.
This is a demo store. No orders will be fulfilled.
Ralpancizumab (anti-PCSK9) - Primary antibody, specific to PCSK9, >95% (SDS-PAGE&SEC), high purity, Human IgG2SA, INHIBITOR of Subtilisin/kexin type 9 inhibitor, INHIBITOR of Subtilisin/kexin type 9 inhibitor
- Host species: Human
- Reactive species: Human
- Isotype: Human IgG2SA
- Conjugation: Unconjugated
In stock
Item Number
Ab182733
| SKU | Size | Availability |
Price | Qty |
|---|---|---|---|---|
|
Ab182733-100μg
|
100μg |
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
|
$109.90
|
|
|
Ab182733-1mg
|
1mg |
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
|
$519.90
|
|
|
Ab182733-5mg
|
5mg |
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
|
$1,399.90
|
|
|
Ab182733-10mg
|
10mg |
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
|
$2,239.90
|
|
Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG2SA; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated